Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention

NCT02430012 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT02430012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02430012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
September 30, 2017
Enrollment
10,009 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass grafting, secondary preventions